Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02424617
Title A Study of BGB324 in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BerGenBio AS

lung non-small cell carcinoma


Bemcentinib + Erlotinib

Age Groups: adult
Covered Countries USA

No variant requirements are available.